These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21133733)

  • 21. The BH3-only protein Puma plays an essential role in p53-mediated apoptosis of chronic lymphocytic leukemia cells.
    Zhu HJ; Liu L; Fan L; Zhang LN; Fang C; Zou ZJ; Li JY; Xu W
    Leuk Lymphoma; 2013 Dec; 54(12):2712-9. PubMed ID: 23517560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unexpectedly high frequency of European parentage in Venezuelan patients with chronic lymphocytic leukemia.
    Marquez ME; Deglesne PA; Lopez JL; Da Costa O; Borrego M; Hernández M; Muller A; Ajchenbaum-Cymbalista F; Romano E
    Leuk Lymphoma; 2012 Feb; 53(2):235-41. PubMed ID: 21867460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia.
    Fabris S; Bollati V; Agnelli L; Morabito F; Motta V; Cutrona G; Matis S; Grazia Recchia A; Gigliotti V; Gentile M; Deliliers GL; Bertazzi PA; Ferrarini M; Neri A; Baccarelli A
    Epigenetics; 2011 Feb; 6(2):188-94. PubMed ID: 20930513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.
    Catherwood MA; Matthews C; Niblock R; Dobbin E; Morris TC; Alexander HD
    Eur J Haematol; 2006 Apr; 76(4):294-8. PubMed ID: 16519700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.
    Gryshchenko I; Hofbauer S; Stoecher M; Daniel PT; Steurer M; Gaiger A; Eigenberger K; Greil R; Tinhofer I
    J Clin Oncol; 2008 May; 26(14):2252-7. PubMed ID: 18467716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia.
    Rassenti LZ; Jain S; Keating MJ; Wierda WG; Grever MR; Byrd JC; Kay NE; Brown JR; Gribben JG; Neuberg DS; He F; Greaves AW; Rai KR; Kipps TJ
    Blood; 2008 Sep; 112(5):1923-30. PubMed ID: 18577710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
    Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of serum immunoglobulin paraprotein in patients with chronic lymphocytic leukemia.
    Xu W; Wang YH; Fan L; Fang C; Zhu DX; Wang DM; Qiao C; Wu YJ; Li JY
    Leuk Res; 2011 Aug; 35(8):1060-5. PubMed ID: 21208658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of CLLU1 in patients with chronic lymphocytic leukemia and its prognostic significance].
    Chen LJ; Zheng WJ; Wu YJ; Li L; Qian SX; Xu W; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):737-40. PubMed ID: 18457263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of the Fas-inhibitory molecule TOSO: a novel antiapoptotic factor in chronic lymphocytic leukemia.
    Pallasch CP; Wendtner CM
    Leuk Lymphoma; 2009 Mar; 50(3):498-501. PubMed ID: 19347734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
    Kröber A; Seiler T; Benner A; Bullinger L; Brückle E; Lichter P; Döhner H; Stilgenbauer S
    Blood; 2002 Aug; 100(4):1410-6. PubMed ID: 12149225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic nucleotide phosphodiesterase 7B mRNA: an unfavorable characteristic in chronic lymphocytic leukemia.
    Zhang L; Murray F; Rassenti LZ; Pu M; Kelly C; Kanter JR; Greaves A; Messer K; Kipps TJ; Insel PA
    Int J Cancer; 2011 Sep; 129(5):1162-9. PubMed ID: 21120911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia.
    Molica S; Vitelli G; Cutrona G; Todoerti K; Mirabelli R; Digiesi G; Giannarelli D; Sperduti I; Molica M; Gentile M; Morabito F; Neri A; Ferrarini M
    Int J Hematol; 2008 Nov; 88(4):374-380. PubMed ID: 18818986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.
    Kröber A; Bloehdorn J; Hafner S; Bühler A; Seiler T; Kienle D; Winkler D; Bangerter M; Schlenk RF; Benner A; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2006 Feb; 24(6):969-75. PubMed ID: 16418492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemia.
    Alonci A; Allegra A; Bellomo G; D'Angelo A; Penna G; Cannavò A; Musolino C
    Med Oncol; 2010 Dec; 27(4):1336-9. PubMed ID: 20013319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.
    Li FJ; Ding S; Pan J; Shakhmatov MA; Kashentseva E; Wu J; Li Y; Soong SJ; Chiorazzi N; Davis RS
    Blood; 2008 Jul; 112(1):179-87. PubMed ID: 18314442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors.
    Xu W; Cao X; Miao KR; Qiao C; Wu YJ; Liu Q; Fan L; Li JY
    Int J Hematol; 2009 Sep; 90(2):205-211. PubMed ID: 19629630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of ZAP-70 mRNA by real-time PCR is a prognostic factor in chronic lymphocytic leukemia.
    Wang YH; Zou ZJ; Liu L; Zhang LN; Fang C; Zhu DX; Fan L; Li JY; Xu W
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):1011-7. PubMed ID: 22362302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL.
    Majid A; Lin TT; Best G; Fishlock K; Hewamana S; Pratt G; Yallop D; Buggins AG; Wagner S; Kennedy BJ; Miall F; Hills R; Devereux S; Oscier DG; Dyer MJ; Fegan C; Pepper C
    Leuk Res; 2011 Jun; 35(6):750-6. PubMed ID: 21093051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.